Digital postnatal discharge system launched by NHS Trust

A digital postnatal discharge system has been launched by the Chelsea and Westminster Hospital NHS Foundation Trust.

The Lumeon technology software aims to improve the patient experience, increase efficiency and reduce costs. It’s funded by CW+, the Trust’s official charity.

Robbie Hughes, founder and CEO of Lumeon said: “Lumeon is very excited for this opportunity to help Chelsea and Westminster Hospital transform both the patient and staff experience, whilst improving efficiency. The NHS has recently announced both maternity and digital health services as key focus areas in the Long Term Plan. Our work with Chelsea and Westminster has been put into motion at a particularly significant time and we look forward to scaling our innovative system across the NHS, starting with maternity and postnatal pathways.

Lumeon’s Care Pathway Management solution digitises the postnatal pathway. All activities and tasks are orchestrated and automated with the ability to get a good overview of the care being delivered. Digital dashboards allow multi-disciplinary team members to quickly see what they need to do next, and by when, for each patient to meet their discharge slot. Staff are able to communicate more effectively with new mums, and provide a holistic overview relating to them and their baby in relation to getting them ready for home.

Dr Zoe Penn, medical director at Chelsea and Westminster NHS Hospital NHS Foundation Trust, said: “Chelsea and Westminster Hospital NHS Foundation Trust is passionate about health innovation delivering exceptional patient care. Together with our charity CW+, we identify technology partners that will help us excel in these areas. We have worked closely with the Lumeon team and we are excited about this fantastic new system that will help to deliver great care to new mums and their families.”




'Digital postnatal discharge system launched by NHS Trust' has no comments

Be the first to comment this post!

Would you like to share your thoughts?

Your email address will not be published.

This site uses Akismet to reduce spam. Learn how your comment data is processed.

© 2019 Rapid Life Sciences Ltd, a Rapid News Communications Group Company. All Rights Reserved.

Privacy policy

Terms and conditions